Prognosis
23andMe Goes Public as $3.5 Billion Company With Branson Aid
- CEO Wojcicki and SPAC leader Branson each invest $25 million
- DNA-testing company has been expanding its health-care profile
This article is for subscribers only.
Consumer DNA-testing company 23andMe Inc. has entered into a deal to merge with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson.
The agreement values the Silicon Valley company at $3.5 billion, with Chief Executive Officer Anne Wojcicki and Branson each investing $25 million into a $250 million private investment in public equity offering. Bloomberg News reported news of a potential deal last week.